LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection

被引:4
|
作者
Zhang, Chunhui [1 ]
Yang, Rui [1 ]
Wang, Xinxin [2 ]
Tao, Yuqing [1 ]
Tang, Shuli [3 ]
Tian, Zhennan [4 ]
Zhou, Yang [2 ]
机构
[1] Harbin Med Univ Canc Hosp, Dept Gastrointestinal Med Oncol, Harbin, Heilongjiang, Peoples R China
[2] Harbin Med Univ Canc Hosp, Dept Radiol, Harbin, Heilongjiang, Peoples R China
[3] Harbin Med Univ Canc Hosp, Dept Outpatient Chemotherapy, Harbin, Heilongjiang, Peoples R China
[4] Harbin Med Univ Canc Hosp, Dept Pathol, Harbin, Heilongjiang, Peoples R China
关键词
Hepatocellular carcinoma; Magnetic resonance imaging; Morphological classification; Prediction; Prognosis; MACROSCOPIC CLASSIFICATION; INTRAHEPATIC RECURRENCE; RISK-FACTORS; PHASE;
D O I
10.1245/s10434-023-13494-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThis study aimed to explore the association of preoperative magnetic resonance imaging (MRI) tumor morphological classification with early recurrence (ER) and overall survival (OS) after radical surgery of hepatocellular carcinoma (HCC).Patients and MethodsA retrospective analysis of 296 patients with HCC who underwent radical resection was performed. On the basis of LI-RADS, tumor imaging morphology was classified into three types. The clinical imaging features, ER, and survival rates of three types were compared. Univariate and multivariate Cox regression analyses were conducted to identify prognostic factors associated with OS and ER after hepatectomy for HCC.ResultsThere were 167 tumors of type 1, 95 of type 2, and 34 of type 3. In patients with type 3 HCC, postoperative mortality and ER were significantly higher than in patients with type 1 and type 2 (55.9% versus 32.6% versus 27.5% and 52.9% versus 33.7% versus 28.7%). In multivariate analysis, the LI-RADS morphological type was a stronger risk factor for predicting poor OS [hazard ratio (HR) 2.77, 95% confidence interval (CI) 1.59-4.85, P < 0.001] and ER (HR 2.14, 95% CI 1.24-3.70, P = 0.007). A subgroup analysis revealed that type 3 was associated with poor OS and ER in > 5 cm cases but not in < 5 cm cases.ConclusionsER and OS of patients with HCC undergoing radical surgery can be predicted using the preoperative tumor LI-RADS morphological type, which could help to select personalized treatment plans for patients with HCC in the future.
引用
收藏
页码:4876 / 4885
页数:10
相关论文
共 50 条
  • [21] LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis
    Kartalis, Nikolaos
    Grigoriadis, Aristeidis
    RADIOLOGY, 2024, 310 (02)
  • [22] RISK OF PROGRESSION TO HEPATOCELLULAR CARCINOMA IN PATIENTS WITH INDETERMINATE (LI-RADS 3) OBSERVATIONS
    Arvind, Ashwini
    Zaki, Timothy A.
    Yokoo, Takeshi
    Fetzer, David T.
    Browning, Travis
    Rich, Nicole E.
    Marrero, Jorge A.
    Zhu, Hao
    Yopp, Adam
    Hoshida, Yujin
    Gopal, Purva
    Parikh, Neehar D.
    Singal, Amit G.
    GASTROENTEROLOGY, 2021, 160 (06) : S759 - S760
  • [23] CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
    Zhe Huang
    Ping Ping Zhou
    Shan Shan Li
    Kaiyan Li
    Cancer Imaging, 23
  • [24] Lyin' LI-RADS 5: A Case of Misdiagnosed Hepatocellular Carcinoma
    Perry, Isaac E.
    Barrett, Amanda
    Ibrahim, Muaz A.
    Sharma, Amol
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1356 - S1356
  • [25] Diagnostic performance of US LI-RADS in hepatocellular carcinoma surveillance
    Ahmed Haitham Abduljabbar
    Mohammad A. Wazzan
    Egyptian Journal of Radiology and Nuclear Medicine, 54
  • [26] LI-RADS US Surveillance Version 2024 for Surveillance of Hepatocellular Carcinoma: An Update to the American College of US LI-RADS
    Kamaya, Aya
    Fetzer, David T.
    Seow, James H.
    Burrowes, David P.
    Choi, Hailey H.
    Dawkins, Adrian A.
    Fung, Christopher
    Gabriel, Helena
    Hong, Cheng William
    Khurana, Aman
    Mcgillen, Kathryn L.
    Morgan, Tara A.
    Sirlin, Claude B.
    Tse, Justin R.
    Rodgers, Shuchi K.
    RADIOLOGY, 2024, 313 (03)
  • [27] CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
    Huang, Zhe
    Zhou, Ping Ping
    Li, Shan Shan
    Li, Kaiyan
    CANCER IMAGING, 2023, 23 (01)
  • [28] Diagnostic performance of US LI-RADS in hepatocellular carcinoma surveillance
    Abduljabbar, Ahmed Haitham
    Wazzan, Mohammad A.
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2023, 54 (01):
  • [29] Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy
    Razek, A. A. K. Abdel
    El-Serougy, L. G.
    Saleh, G. A.
    Shabana, W.
    Abd El-Wahab, R.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2020, 101 (09) : 547 - 553
  • [30] Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma
    Cannella, Roberto
    Matteini, Francesco
    Burgio, Marco Dioguardi
    Sartoris, Riccardo
    Beaufrere, Aurelie
    Calderaro, Julien
    Mule, Sebastien
    Reizine, Edouard
    Luciani, Alain
    Laurent, Alexis
    Seror, Olivier
    Ganne-Carrie, Nathalie
    Wagner, Mathilde
    Scatton, Olivier
    Vilgrain, Valerie
    Cauchy, Francois
    Hobeika, Christian
    Ronot, Maxime
    RADIOLOGY, 2024, 310 (02)